Specify a stock or a cryptocurrency in the search bar to get a summary
AddLife AB (publ)
0REZAddLife AB (publ), together with its subsidiaries, provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates through Labtech and Medtech segments. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory equipment for plastic consumables, cell biology, reagents, lab, and other instruments. The Medtech segment provides medical device products for surgery, thoracic medicine, neurology, wound care, anaesthesia, intensive care, ear, nose and throat, ostomies, and home healthcare, as well as assistive technology for senior citizens and disabled children. It operates in Sweden, the United Kingdom, Ireland, Spain, Denmark, Norway, Italy, Finland, Switzerland, Germany, rest of Europe, and internationally. AddLife AB (publ) was founded in 1906 and is based in Stockholm, Sweden. Address: Brunkebergstorg 5, Stockholm, Sweden, 103 62
Analytics
WallStreet Target Price
1 708.35 SEKP/E ratio
168.4375Dividend Yield
0.31 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 0REZ
Dividend Analytics 0REZ
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
33 %Dividend History 0REZ
Stock Valuation 0REZ
Financials 0REZ
Results | 2019 | Dynamics |